Jacob Gottlieb, a successful entrepreneur and the founder of several investment firms including Visium Asset Management and Altium Capital, is a graduate of Brown University with a BA in Economics and MD degree from New York University School of Medicine. Gottlieb interest lied on investment, and after his medical internship, he began working for financial industries. In 2001, Investment Management and Research Association awarded Gottlieb with Financial Analyst Charter. Before this, he was appointed by Professional Risk Managers` International Association as a Professional Risk Manager.
Visium Asset Management was founded in 2005, with offices in New York, London, and San Francisco and has over 200 employees. The firm proliferated leading with $8 billion hedge fund as by 2016 although the company was faced with trading scandals, dismissing all its workers. Gottlieb was declared free from wrongdoing associated to the scandal and remained as the only key executive. Before founding Visium Asset Management, Gottlieb invested with Balyasny Asset Management where he became top earner through his large portfolio gain. He also worked at Sanford C. Bernstein as a buy-side analyst covering global health care.
Recently Jacob Gottlieb launched Altium Capital with the aim of broadening healthcare investment. Altium firm is located in New York City and has started with a focus of seizing opportunities available to help companies grow, mostly in the healthcare sector. Altium has ventured its investment in some of leading companies which include, Amarin Corporation, Oramed Pharmaceuticals, and Oragenics.
The Oramed company through its expertise employees developed an oral treatment for diabetic an alternative for injectable drugs diabetic patients have been receiving. Altium first Investment Stake at Oramed was 5.61%. Amarin is a fast growing innovative company with its offices in Bedminster, New Jersey. They specialize in cardiovascular health developing improved drugs. Finally, Oragenics, which was founded in 1996 aims at giving the best treatments against infectious diseases through the production of effective antibiotics.
Find out more about Jacob Gottlieb Altium: https://www.cnbc.com/jacob-gottlieb–cnbc/